Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

• Main Authors: Jabbour, E., Kantarjian, H.M., Saglio, G., Steegmann, J.L., Shah, N.P., Boqué, C., Chuah, C., Pavlovsky, C., Mayer, J., Cortes, J., Baccarani, M., Kim, D.-W., Bradley-Garelik, M.B., Mohamed, H., Wildgust, M., Hochhaus, A.
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Article
• Published: 2016
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/128648
• Institution: National University of Singapore

10.1182/blood-2013-06-511592